Global Pharmacovigilance Market To Reach US$5 bn by 2020

“The Latest Research Report Pharmacovigilance Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Pharmacovigilance Market

Intensifying regulatory expectations, tougher inspection system, and instant need for patient reporting boost the adoption rate of pharmacovigilance among pharmaceutical companies. Rise in the prevalence of acute and chronic diseases has consequently led to an increase in the incidences of drug consumption, thus leading to growth in the number of adverse drug events and drug toxicity cases. Furthermore, safety regulations, risk of high-profile safety issues, large volume of post-market events to be reviewed along with negative media coverage have bound the pharmaceutical players to take support of various outsourcing services for drug monitoring. Two major outsourcing providers preferred by pharmaceutical manufacturers for pharmacovigilance services are namely, traditional CROs (e.g. Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs (e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.). Outsourcing services do not only help in cost saving, but also support process efficiency. Pharmaceutical companies are now entering into long-term partnerships/service agreements with CROs and BPOs to reduce the pharmacovigilance process related expenditure, incurred right from drug discovery to post-marketing approvals. In addition, pharmacovigilance requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting due to which pharmaceutical companies are opting for outsourced pharmacovigilance services in order to reduce the burden of clerical functions as well as capital expenditures.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/180425

This report provides a detailed analysis of the global pharmacovigilance market and assists in understanding various market regulating factors. The market overview section in this report provides analysis of the overall market trends and market dynamics such as market driving factors, restraining factors, and opportunities, which currently administrate the dynamics of the overall pharmacovigilance market. Additionally, the segment also provides and predicts the future circumstances of the market. Market monitoring tools such as Porter’s five forces analysis is also included in this study to provide analysis about the competition in the pharmacovigilance market and market attractiveness in various regions across the world. Competitive analysis tools such as market share analysis and market attractive analysis have also been included in the market overview section of the report to deliver a comprehensive status of the players in the global pharmacovigilance market. The executive summary provided in this report reflects the highlights of the study scope and the overall market in a summarized form. Furthermore, it includes a market snapshot, which provides a glance at the current scenario of the global pharmacovigilance market in terms of current and future market size and growth.

The global pharmacovigilance market is segmented on the basis of clinical trial phases, type of methods, service providers, and geography. Based on clinical trial phases, the pharmacovigilance market is segmented into preclinical studies, phase I trial, phase II trial, phase III trial, and phase IV trial (post marketing surveillance). Based on the methods, this study segments the market into spontaneous reporting, targeted reporting, cohort event monitoring, Intensified ADR, and Reporting EHR mining. Based on service providers, the global pharmacovigilance market is categorized into in-house and contract outsourcing. The market size estimations for the period from 2012 to 2020 have been provided for each segment in terms of USD million. Compounded annual growth rates (CAGR %) for each segment has been provided for the period between 2014 and 2020, considering 2013 as the base year.

View Sample PDF @ https://www.marketresearchreports.biz/reports/180425/pharmacovigilance-phases-of-drug-development-market-research-reports.pdf

In terms of regional analysis, the global pharmacovigilance market has been segmented into four key geographies: North America, Europe, Asia Pacific, and Rest of World (RoW). Market revenue estimations for each of these geographies have been provided in the report for the period from 2012 to 2020 in terms of USD million, considering 2013 as the base year for calculations and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations. This study also provides recommendations for players of the global pharmacovigilance market, which include aspects that may play a decisive role in improving the market share.

The report concludes with in-depth profiles of leading players, which include key information about the major organizations dynamically involved in the global pharmacovigilance market. The report profiles the key market players in terms of company overview, financial overview, product portfolio, business strategies, and recent developments. The key companies profiled in this study are Accenture, Plc, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc. ICON, Plc, iMED Global Corporation, inVentiv Health, Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, PRA Health Sciences, Inc., Quintiles Transnational Holdings Inc, F. Hoffmann-La Roche Ltd., Sanofi , Synowledge LLC, Wipro Limited. Market share analysis of the organizations operating in the pharmacovigilance market would help new entrants to understand key business policies and identify product portfolio of established companies.

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/180425

The global pharmacovigilance market is segmented as follows:

Pharmacovigilance Market, by Phases of Drug Development

Preclinical Studies

Phase I

Phase II

Phase III

Phase IV or Post Marketing Surveillance

Pharmacovigilance Market, by Type of Methods

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Pharmacovigilance Market, by Type of Service

In-House

Contract Outsourcing

Pharmacovigilance Market, by Geography

North America

Europe

Asia Pacific

Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

1.1 Report Description

1.2 Research Methodology

1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Global Pharmacovigilance Market Dynamics

3.1 Introduction

3.2 Market Drivers

3.2.1 Increasing Consumption of Drugs Would Fuel Demand for Continuous Drug Event Monitoring

3.2.2 Rise in the Cases of Adverse Drug Reactions and Drug Toxicity Would Boost Demand for Pharmacovigilance Activities

3.2.3 Rise in Adoption of Outsourcing Services Expected to Accentuate the Market Growth

3.3 Market Restraints

3.3.1 High Risk Associated with Data Security in Pharmacovigilance Outsourcing

3.3.2 Lack of Availability of Skilled Labor might Hinder the Market Growth

3.3.3 Inadequate Pharmacovigilance System for Herbal Products in Asia Pacific Might Hamper the Market Growth

3.4 Market Opportunities

3.4.1 Huge Scope for Rapid Growth of Pharmacovigilance Market in Emerging Economies

3.4.2 Shift in Preference for Outsourcing among Various Pharmaceutical and Life Sciences Companies

3.5 Porter’s Five Forces Analysis: Global Pharmacovigilance Market

3.5.1 Bargaining Power of Suppliers

3.5.2 Bargaining Power of Buyers

3.5.3 Threat of Substitutes

3.5.4 Threat of New Entrants

3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Pharmacovigilance Market, by Geography

3.7 Competitive Landscape

3.7.1 Market Share Analysis: Global Pharmacovigilance Market, 2013 (Value %)

Chapter 4 Global Pharmacovigilance Market, by Phases of Drug Development

4.1 Overview

4.1.1 Global Pharmacovigilance Market Revenue, by Phases of Drug Development, 2012 – 2020 (USD Million)

4.1.2 Comparative Analysis: Global Pharmacovigilance Market Revenue, by Type of Clinical Trial Phases, 2013 & 2020 (Value %)

4.2 Preclinical Studies

4.2.1 Global Preclinical Studies Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million)

4.3 Phase I

4.3.1 Global Phase I Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million)

4.4 Phase II

4.4.1 Global Phase II Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million)

4.5 Phase III

4.5.1 Global Phase III Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million)

4.6 Phase IV or Post Marketing Surveillance

4.6.1 Global Phase IV Clinical Trial Pharmacovigilance Market Revenue, 2012 – 2020 (USD Million)

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: